Relaxed and Healthy (02661) will be open for subscription from December 15th to December 18th. It is expected to be listed on December 23rd.

Relaxed Health (02661) will be listed from December 15th to December 18th, 2025, with a total of 26.54 million shares being offered globally. Of these, 10% will be offered in Hong Kong and 90% internationally, with an additional 15% over-allotment option. The offering price is set at HK$22.68 per share, with a minimum subscription of 200 shares per lot. Trading of the shares is expected to begin on the Hong Kong Stock Exchange on December 23rd, 2025. The company provides health-related and insurance-related solutions. According to data from the Sullivan Report based on revenue in 2024, the company ranks 10th in the Chinese digital comprehensive health services and health insurance services market. The company is dedicated to providing affordable, accurate, and user-friendly health solutions to provide protection and support to those in need. For users seeking comprehensive health solutions, the company offers health-related services such as early disease screening promotions and consultations, health check-ups and consultations, medical appointment services, and health product sales. As an important part of the company's services, it also empowers industry participants to plan quality popular science content through digital marketing and promote health-related public initiatives. In order to support users' health expenses and meet their protection needs, the company also provides insurance-related services through its internet insurance platform, offering users convenient access to a variety of health insurance products. The company's integrated platform provides health services and insurance funding resources to meet users' overall health needs. The group has entered into a cornerstone investment agreement with Aoqin Heming Investments, a partner enterprise in the Guangdong-Hengqin-Macao Deep Cooperation Zone, whereby Aoqin Heming has agreed to subscribe or cause its designated entity to subscribe for approximately RMB 100 million worth of sale shares at the offering price. Calculated at the offering price of HK$22.68 per share, Aoqin Heming will subscribe to a total of 4.8018 million shares. Based on the offering price of HK$22.68 per share (assuming the over-allotment option is not exercised), the net proceeds from the global offering are expected to be approximately HK$513.4 million. The group plans to utilize the net proceeds from the global offering as follows: around 40.0% for enhancing the group's brand awareness, increasing user engagement, and strengthening cooperation with business partners; around 20.0% for medical research and real-world research; around 20.0% for enhancing the group's technological capabilities in AI and big data for wider application in the group's products and services; around 10.0% for expanding into more regions and overseas markets; and around 10.0% for operating funds and other general corporate purposes.